Royalty Pharma Plc (RPRX)

Royalty Pharma Plc (RPRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $36.9B; returns 1 day +0.2%, 1 week +4.8%, 1 year +73.3%.

Royalty Pharma plc (RPRX) is the world's largest buyer of biopharmaceutical royalties, holding over 60% global market share. Founded in 1996, the company acquires royalty streams from approved and late-stage biopharmaceutical products, providing non-dilutive financing to drug developers and rights holders.

Groups RPRX belongs to

• Dividend Payers
• Buying Back Stock
• Royalty Streams
• Biopharmaceutical
• Healthcare
• Life Sciences
• Asset Management
• Financials Sector
• Biotechnology
• Pharmaceuticals
• Rare Diseases

RPRX financial model: income statement, cash flow and balance sheet